|
Volumn 17, Issue 17, 2003, Pages 2544-2545
|
Efavirenz-containing highly active antiretroviral therapy in an HIV-infected patient with myasthenia gravis [2]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CORTICOSTEROID;
EFAVIRENZ;
LAMIVUDINE;
PROTEINASE INHIBITOR;
PYRIDOSTIGMINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ZIDOVUDINE;
ADULT;
BRAZIL;
CASE REPORT;
CLINICAL FEATURE;
ELECTROMYOGRAM;
ELECTROPHYSIOLOGY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOCOMPETENCE;
LETTER;
MALE;
MYASTHENIA GRAVIS;
MYOPATHY;
NEUROPATHY;
PRIORITY JOURNAL;
REMISSION;
THYMECTOMY;
TREATMENT OUTCOME;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MYASTHENIA GRAVIS;
OXAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
|
EID: 1642317452
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200311210-00022 Document Type: Letter |
Times cited : (4)
|
References (6)
|